Catalyst Wire Dossier Catalyst Wire Dossier

ER OROS Paliperidone

paliperidone · Johnson & Johnson Pharmaceutical Research, L.L.C.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ER OROS Paliperidone, covering 2011-05-24 to 2012-07-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia [Phase 3]

See pricing